SCNI Stock Price and Chart — NASDAQ:SCNI

Overview

Financials News Discussions Technicals Seasonals

SCNI chart

About Scinai Immunotherapeutics Ltd.

Scinai Immunotherapeutics Ltd. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunomodulation therapies for infectious diseases. It focuses on the flu vaccine candidate that was designed to provide multi-strain and multi-season protection against seasonal and pandemic influenza. The company was founded by Ronald Babecoff and Rami Epstein on July 21, 2003 and is headquartered in Jerusalem, Israel.

Financials

Performance

‪−2,100.0%‬

‪0.0%‬

‪2,100.0%‬

‪4,200.0%‬

‪6,300.0%‬

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

‪‪−4.00 M‬‬

‪0.00‬

‪‪4.00 M‬‬

‪‪8.00 M‬‬

‪‪12.00 M‬‬

Revenue

Net income

Net margin %

Revenue to profit conversion

Revenue

COGS

Gross profit

Op expenses

Op income

Non-Op income/ expenses

Taxes & Other

Net income

‪‪−4.00 M‬‬

‪0.00‬

‪‪4.00 M‬‬

‪‪8.00 M‬‬

‪‪12.00 M‬‬

Revenue

COGS

Gross profit

Expenses & adjustments

Net income

‪‪−4.00 M‬‬

‪0.00‬

‪‪4.00 M‬‬

‪‪8.00 M‬‬

‪‪12.00 M‬‬

Debt level and coverage

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

‪‪−7.00 M‬‬

‪0.00‬

‪‪7.00 M‬‬

‪‪14.00 M‬‬

‪‪21.00 M‬‬

Debt

Free cash flow

Cash & equivalents

Earnings

Next:May 29, 2025

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

‪−6.30‬

‪−4.20‬

‪−2.10‬

‪0.00‬

‪2.10‬

Actual

Estimate

No news here

Looks like there's nothing to report right now

Technicals

Summarizing what the indicators are suggesting.

Oscillators

Neutral

SellBuy

Strong sellStrong buy